Ifinatamab

• Description :

  Ifinatamab is monoclonal immunoglobulin G1-kappa with anti-human B7 homolog 3 protein (Human B7-H3) . Ifinatamab is a glycoforme α immunomodulateur[1].

• CAS Number :

  [2484870-90-6]

• Product Name Alternative :

  DS-7300a Antibody; MABX-9001A Antibody

• UNSPSC :

  12352203

• Target :

  CD276/B7-H3

• Type :

  Inhibitory Antibodies

• Related Pathways :

  Immunology/Inflammation

• Applications :

  COVID-19-immunoregulation

• Field of Research :

  Inflammation/Immunology; Cancer

• Assay Protocol :

  https://www.medchemexpress.com/ifinatamab.html

• Purity :

  99.94

• Solubility :

  10 mM in DMSO

• Smiles :

  [Ifinatamab]

• Molecular Weight :

  (146.24 kDa)

• References & Citations :

  [1]WHO Drug Information. International Nonproprietary Names for Pharmaceutical.

• Shipping Conditions :

  Dry Ice

• Storage Conditions :

  Store at -80°C for 2 years

• Scientific Category :

  Inhibitory Antibodies

• Clinical Information :

  Phase 3